Adalis M.
About Adalis M.
Adalis M. serves as the NGS Clinical Laboratory Supervisor at Variantyx, where she has worked since 2021. She holds a Bachelor's degree in Biology and Mathematics from Regis College and a Master's degree in Acupuncture and Oriental Medicine from Massachusetts College of Pharmacy and Health Sciences.
Work at Variantyx
Adalis M. serves as the NGS Clinical Laboratory Supervisor at Variantyx. She has held this position since 2021. In this role, she oversees next-generation sequencing operations, ensuring quality and efficiency in laboratory processes. Her expertise contributes to the advancement of genomic testing and analysis within the organization.
Education and Expertise
Adalis M. holds a Bachelor's degree in Biology/Biological Sciences and Mathematics from Regis College, which she completed from 2003 to 2007. She furthered her education by obtaining a Master's degree in Acupuncture and Oriental Medicine from the Massachusetts College of Pharmacy and Health Sciences, studying from 2020 to 2023. This diverse academic background equips her with a strong foundation in both scientific and holistic health disciplines.
Background in Research and Technology
Adalis M. has extensive experience in the research and technology sectors. She worked as a Research Technician in the Molecular Biology Core Facilities at Dana-Farber Cancer Institute from 2007 to 2014. Following this, she served as a Senior Research Technologist in the Next Generation Sequencing Core at Massachusetts General Hospital from 2014 to 2019. Her role at Sanofi as a Senior Associate Scientist from 2019 to 2021 further solidified her expertise in scientific research and development.
Professional Experience Timeline
Adalis M.'s professional journey includes significant roles at various prestigious institutions. After starting her career at Dana-Farber Cancer Institute, she transitioned to Massachusetts General Hospital, where she spent five years. She then moved to Sanofi for two years before joining Variantyx. Her career reflects a commitment to advancing the field of genomics and molecular biology.